Psychedelic-Assissted Therapy for Veterans and Personality Improvement
Psychedelic-assisted therapy at the VA
Psychedelic-assisted therapy has recently gained mainstream acceptance among civilians, but what about for members of the military and veterans?
This therapy may soon be an option for some veterans. As “Lucid” reports, “psychedelic-assisted therapy is on the rise at some veterans administration hospitals.”
Phase 3 clinical trials of MDMA therapy to treat post-traumatic stress disorder have been so successful, with 68 percent of participants in remission, the FDA granted MDMA a special ‘Breakthrough Therapy’ designation. But this therapy is not yet available all over the country, prompting more researchers to call on the VA to create protocols for MDMA, psilocybin, and ketamine therapies. These psychedelics are still classified as Schedule 1 narcotics, and it will take political will and bipartisan support to win FDA approval.
If that happens, researchers at the forefront of these therapies hope to see VA hospitals nationwide using psychedelics to help veterans by the year 2024.
Could the use of hallucinogens actually improve your personality?
A new study published in the journal Frontiers in Psychology looked at how psychedelics affect personality. Researchers recruited adults who were planning on using hallucinogens in the near future and asked them to fill out a survey regarding their personality, based on the five-factor model of personality traits:
- Extraversion
- Neuroticism
- Openness to experience
- Agreeableness
- Conscientiousness
Participants took the survey three times — before their psychedelic experience, two weeks after, and four weeks after. The results were impressive, with people reporting a reduction in neuroticism and an increase in agreeableness, even four weeks after their experience.
Brandon Weiss, a psychologist at Imperial College London and lead researcher told Psychology Today, “[F]irst, people seemed to report that they were not as quarrelsome or critical in their interactions with others. Second, people reported that they were less easily upset by things and less anxious.”
Weiss also pointed out that despite these positive outcomes, hallucinogens can be dangerous, especially with people who have pre-existing psychosis. More data is needed to confirm the studies’ findings. As a large number of participants did not follow through with the entire survey. But this is more evidence that hallucinogens could be another tool to help with mental health.
Study Shows Microdosing Psilocybin Boosts Mood, Mental Health
A new study provides the most compelling evidence to date on the impressive mental health benefits of microdosing psilocybin.
While there has been an ever-increasing number of studies showing the efficacy of treatment of mental health disorders with psychedelics, there has been relatively little research on the practice of microdosing.Â
Microdosing, or repeatedly taking small, barely perceptible amounts of psychedelics, has been exponentially increasing in popularity, with a wide range of people reporting a multitude of improvements to their psychological wellbeing.
The latest scientific study to look at the effects of microdosing was conducted by researchers at the University of British Columbia, as well as other leaders in the fields of psychology and mycology. The study followed 953 people who used small, repeated doses of psilocybin for about 30 days, as well as a control group who did not microdose.
While the exact dosages of psylocibin that participants self-administered varied somewhat, they were all low enough to not impact daily functioning.
Over a one-month period, participants took these psylocibin microdoses three to five times per week and were asked to complete a number of assessments through a smartphone app that tracked their mental health symptoms, mood, and measures of cognition. The findings definitively showed that the microdosing participants demonstrated greater improvements in mood and mental health than those in the non-microdosing control group.
